🚀 VC round data is live in beta, check it out!
Kusuri No Aoki Valuation Multiples
Discover revenue and EBITDA valuation multiples for Kusuri No Aoki and similar public comparables like Ebos Group, Fragua, Omnicell, Dis-Chem Pharmacies and more.
Kusuri No Aoki Overview
About Kusuri No Aoki
Kusuri No Aoki Holdings is a pharmaceutical retail chain that sells health, beauty, and cleaning supplies. The company operates stores that focus primarily on residential areas in Japan. Kusuri's business includes pharmaceutical drugs, and the company also operates a bone-marrow bank. The company breaks out its sales into four different product lines, including health, beauty, life, and dispensing. The vast majority of the company's revenue is derived from its life product category, followed by beauty products. Most of Kusuri's revenue is derived from the Hokuriku region.
Founded
1999
HQ
Employees
8.0K
Website
Sectors
Financials (LTM)
EV
$3B
Kusuri No Aoki Financials
Kusuri No Aoki reported last 12-month revenue of $4B and EBITDA of $255M.
In the same LTM period, Kusuri No Aoki generated $255M in EBITDA and $114M in net income.
Revenue (LTM)
Kusuri No Aoki P&L
In the most recent fiscal year, Kusuri No Aoki reported revenue of $3B and EBITDA of $270M.
Kusuri No Aoki expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $4B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $837M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 24% | XXX | XXX | XXX |
| EBITDA | $255M | XXX | $270M | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 8% | XXX | XXX | XXX |
| EBIT Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $114M | XXX | $123M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | — | — | $286M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Kusuri No Aoki Stock Performance
Kusuri No Aoki has current market cap of $2B, and enterprise value of $3B.
Market Cap Evolution
Kusuri No Aoki's stock price is $25.31.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $2B | 0.1% | XXX | XXX | XXX | $1.30 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialKusuri No Aoki Valuation Multiples
Kusuri No Aoki trades at 0.8x EV/Revenue multiple, and 11.4x EV/EBITDA.
EV / Revenue (LTM)
Kusuri No Aoki Financial Valuation Multiples
As of March 19, 2026, Kusuri No Aoki has market cap of $2B and EV of $3B.
Equity research analysts estimate Kusuri No Aoki's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Kusuri No Aoki has a P/E ratio of 21.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 11.4x | XXX | 10.8x | XXX | XXX | XXX |
| EV/EBIT | 17.3x | XXX | 15.8x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.5x | XXX | XXX | XXX |
| P/E | 21.1x | XXX | 19.5x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (10743.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Kusuri No Aoki Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Kusuri No Aoki Margins & Growth Rates
Kusuri No Aoki's revenue in the last 12 month grew by 10%.
Kusuri No Aoki's revenue per employee in the last FY averaged $0.4M.
Kusuri No Aoki's rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Kusuri No Aoki's rule of X is 33% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Kusuri No Aoki Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | (7%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 18% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 33% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 19% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Kusuri No Aoki Public Comps
See public comps and valuation multiples for other Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Ebos Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Fragua | XXX | XXX | XXX | XXX | XXX | XXX |
| Omnicell | XXX | XXX | XXX | XXX | XXX | XXX |
| Dis-Chem Pharmacies | XXX | XXX | XXX | XXX | XXX | XXX |
| Sundrug | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Kusuri No Aoki M&A Activity
Kusuri No Aoki acquired XXX companies to date.
Last acquisition by Kusuri No Aoki was on XXXXXXXX, XXXXX. Kusuri No Aoki acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Kusuri No Aoki
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialKusuri No Aoki Investment Activity
Kusuri No Aoki invested in XXX companies to date.
Kusuri No Aoki made its latest investment on XXXXXXXX, XXXXX. Kusuri No Aoki invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Kusuri No Aoki
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Kusuri No Aoki
| When was Kusuri No Aoki founded? | Kusuri No Aoki was founded in 1999. |
| Where is Kusuri No Aoki headquartered? | Kusuri No Aoki is headquartered in Japan. |
| How many employees does Kusuri No Aoki have? | As of today, Kusuri No Aoki has over 8K employees. |
| Is Kusuri No Aoki publicly listed? | Yes, Kusuri No Aoki is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Kusuri No Aoki? | Kusuri No Aoki trades under 3549 ticker. |
| When did Kusuri No Aoki go public? | Kusuri No Aoki went public in 2006. |
| Who are competitors of Kusuri No Aoki? | Kusuri No Aoki main competitors are Ebos Group, Fragua, Omnicell, Dis-Chem Pharmacies. |
| What is the current market cap of Kusuri No Aoki? | Kusuri No Aoki's current market cap is $2B. |
| What is the current revenue of Kusuri No Aoki? | Kusuri No Aoki's last 12 months revenue is $4B. |
| What is the current revenue growth of Kusuri No Aoki? | Kusuri No Aoki revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Kusuri No Aoki? | Current revenue multiple of Kusuri No Aoki is 0.8x. |
| Is Kusuri No Aoki profitable? | Yes, Kusuri No Aoki is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Kusuri No Aoki? | Kusuri No Aoki's last 12 months EBITDA is $255M. |
| What is Kusuri No Aoki's EBITDA margin? | Kusuri No Aoki's last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of Kusuri No Aoki? | Current EBITDA multiple of Kusuri No Aoki is 11.4x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.